Viridian Therapeutics, Inc.\DE (VRDN) EPS (Basic) (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly EPS (Basic) of -$1.09 for Q1 2026, up 5.54% year-over-year from -$1.04 in Q1 2025, and up 6.63% quarter-over-quarter from -$1.17 in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) EPS (Basic) (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's EPS (Basic) history runs 14 years deep, the most recent figure standing at -$1.09 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 5.54% year-over-year to -$1.09; the TTM figure through Mar 2026 stood at -$3.5 (up 15.68% YoY), while the FY2025 annual figure was -$7.7, down 9.8% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.09, up from -$1.17 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.43 in Q3 2025, with the low at -$1.88 in Q4 2023.
- The 5-year median for EPS (Basic) is -$1.16 (2025), against an average of -$1.18.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) sank 64.14% in 2023, then surged 68.88% in 2025.
- Viridian Therapeutics, Inc.\DE's EPS (Basic) stood at -$1.42 in 2022, then tumbled by 32.32% to -$1.88 in 2023, then jumped by 38.06% to -$1.17 in 2024, then fell by 0.51% to -$1.17 in 2025, then climbed by 6.63% to -$1.09 in 2026.
- Business Quant data shows VRDN's EPS (Basic) at -$1.09 in Q1 2026, -$1.17 in Q4 2025, and -$0.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | -1.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.49 |
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -1.17 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -1.37 |
| Mar 31, 2025 | -1.16 |
| Dec 31, 2024 | -1.17 |
| Sep 30, 2024 | -1.38 |
| Jun 30, 2024 | -1.14 |
| Mar 31, 2024 | -0.94 |
| Dec 31, 2023 | -1.88 |
| Sep 30, 2023 | -1.09 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -1.61 |
| Dec 31, 2022 | -1.42 |
| Sep 30, 2022 | -0.86 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -0.98 |
| Dec 31, 2021 | -2.43 |
| Sep 30, 2021 | -1.26 |